S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
Ohio foundation begins process to distribute millions in opioid settlement money
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
Ohio foundation begins process to distribute millions in opioid settlement money
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
Ohio foundation begins process to distribute millions in opioid settlement money
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
Ohio foundation begins process to distribute millions in opioid settlement money

OncoSec Medical (ONCSQ) Competitors

ONCSQ vs. ADCT, GHRS, GRFS, LVTX, MYNZ, NLSP, PHVS, PROC, QLI, and SIOX

Should you be buying OncoSec Medical stock or one of its competitors? The main competitors of OncoSec Medical include ADC Therapeutics (ADCT), GH Research (GHRS), Grifols (GRFS), LAVA Therapeutics (LVTX), Mainz Biomed (MYNZ), NLS Pharmaceutics (NLSP), Pharvaris (PHVS), Procaps Group (PROC), Qilian International Holding Group (QLI), and Sio Gene Therapies (SIOX). These companies are all part of the "pharmaceutical preparations" industry.

OncoSec Medical vs.

ADC Therapeutics (NYSE:ADCT) and OncoSec Medical (NASDAQ:ONCSQ) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, community ranking, valuation, earnings, dividends and media sentiment.

ADC Therapeutics received 45 more outperform votes than OncoSec Medical when rated by MarketBeat users.

CompanyUnderperformOutperform
ADC TherapeuticsOutperform Votes
45
61.64%
Underperform Votes
28
38.36%
OncoSec MedicalN/AN/A

ADC Therapeutics has a beta of 1.75, indicating that its stock price is 75% more volatile than the S&P 500. Comparatively, OncoSec Medical has a beta of -18.47, indicating that its stock price is 1,947% less volatile than the S&P 500.

OncoSec Medical has lower revenue, but higher earnings than ADC Therapeutics. ADC Therapeutics is trading at a lower price-to-earnings ratio than OncoSec Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ADC Therapeutics$209.91MN/A-$155.80M-$2.20-2.10
OncoSec MedicalN/AN/A-$34.18M-$15.29N/A

OncoSec Medical has a net margin of 0.00% compared to OncoSec Medical's net margin of -145.64%. ADC Therapeutics' return on equity of 0.00% beat OncoSec Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
ADC Therapeutics-145.64% -1,121.94% -36.23%
OncoSec Medical N/A N/A N/A

ADC Therapeutics currently has a consensus price target of $6.33, indicating a potential upside of 36.79%.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ADC Therapeutics
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
OncoSec Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, ADC Therapeutics had 4 more articles in the media than OncoSec Medical. MarketBeat recorded 4 mentions for ADC Therapeutics and 0 mentions for OncoSec Medical. OncoSec Medical's average media sentiment score of 0.28 beat ADC Therapeutics' score of 0.00 indicating that ADC Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
ADC Therapeutics Neutral
OncoSec Medical Neutral

67.3% of ADC Therapeutics shares are owned by institutional investors. Comparatively, 17.3% of OncoSec Medical shares are owned by institutional investors. 35.4% of ADC Therapeutics shares are owned by company insiders. Comparatively, 1.3% of OncoSec Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

ADC Therapeutics beats OncoSec Medical on 9 of the 13 factors compared between the two stocks.


Get OncoSec Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONCSQ and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ONCSQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ONCSQ vs. The Competition

MetricOncoSec MedicalPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market CapN/A$6.70B$4.96B$7.61B
Dividend YieldN/A2.83%2.87%3.87%
P/E RatioN/A7.87184.6713.79
Price / SalesN/A228.962,833.0775.94
Price / CashN/A20.8332.7028.77
Price / BookN/A5.034.484.46
Net Income-$34.18M$151.35M$112.67M$212.60M

OncoSec Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADCT
ADC Therapeutics
3.3435 of 5 stars
$4.99
-0.4%
$6.33
+26.9%
+47.5%$0.00$209.91M-2.27317
GHRS
GH Research
1.9155 of 5 stars
$8.10
-7.1%
$40.67
+402.1%
-22.6%$0.00N/A-10.2532Earnings Report
Upcoming Earnings
Analyst Report
News Coverage
GRFS
Grifols
3.8466 of 5 stars
$9.19
-1.2%
$10.50
+14.3%
-22.5%$0.00$6.39B0.0026,314
LVTX
LAVA Therapeutics
2.8264 of 5 stars
$2.12
flat
$6.00
+183.0%
+24.2%$0.00$19.39M-1.1069News Coverage
Gap Down
MYNZ
Mainz Biomed
3.1369 of 5 stars
$0.91
+0.6%
$7.00
+672.6%
-87.2%$0.00$530,000.000.0058Short Interest ↓
NLSP
NLS Pharmaceutics
0 of 5 stars
$0.39
-1.3%
N/A-75.0%$0.00N/A0.006Gap Up
PHVS
Pharvaris
3.3266 of 5 stars
$25.36
+3.7%
$29.75
+17.3%
+167.0%$0.00N/A-7.8870
PROC
Procaps Group
3.7207 of 5 stars
$3.08
+0.7%
$4.50
+46.1%
-19.0%$0.00$409.92M5.925,500News Coverage
QLI
Qilian International Holding Group
0 of 5 stars
$0.54
-3.5%
N/A-61.6%$0.00$46.47M0.00345Gap Down
SIOX
Sio Gene Therapies
0 of 5 stars
$0.48
+1.7%
N/A+16.0%$0.00N/A0.0012Gap Down

Related Companies and Tools

This page (NASDAQ:ONCSQ) was last updated on 3/5/2024 by MarketBeat.com Staff